Healthy volunteers sought for first human tests of experimental drug JZP047
NCT ID NCT07377539
First seen Jan 31, 2026 · Last updated May 19, 2026 · Updated 12 times
Summary
This early-stage study tests the safety of a new drug, JZP047, in healthy adults aged 18 to 55. Participants receive either a single dose of the drug or a placebo, and researchers monitor side effects and how the drug moves through the body. A separate part looks at whether food changes drug absorption. This study does not aim to treat any disease.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEALTHY PARTICIPANTS are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Celerion, Inc.
RECRUITINGLincoln, Nebraska, 68502, United States
Conditions
Explore the condition pages connected to this study.